is tirzepatide lizard venom In the 1980s, researchers at the NIH were studying something that seemed purely curiosity-driven: from the Gila monster, a desert lizard. What they found changed medicine. A molecule in that venom — Gila monster: meet the lizard

To view or add a comment, sign in GLP-1 medications show cost-effectiveness for obesity, but interpretation demands caution: most models rely on long-term assumptions, high US cost thresholds, and limited real-world data

Ammori BJ, Fitzgerald P, Hawkey P, et al

Additional testing may be considered for people with a family history of premature heart disease, metabolic risk, abnormal cholesterol results, known cardiovascular disease, or uncertainty after standard testing: ApoB, Lp(a), and hs-CRP may help reveal particle burden, inherited risk, and inflammation that are not fully captured by LDL cholesterol alone

This also means that we must tailor the plan to the patient's resource availability

[2] [3] This substantial genetic contribution means that some people are indeed born with a predisposition toward higher or lower metabolic rates, independent of their lifestyle choices

Jastreboff said